8606 related articles for article (PubMed ID: 18088454)
1. [Expression of PRAME gene in acute leukemia and its clinical significance].
Zhu YL; Liu J; Zhu P; DU JW; Zhang Y; Gu JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1144-9. PubMed ID: 18088454
[TBL] [Abstract][Full Text] [Related]
2. [Expression of PRAME gene in adult acute leukemia and its significance in prognosis].
Zhou PY; Li WJ; Wei CX; Zhou Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1177-81. PubMed ID: 18088461
[TBL] [Abstract][Full Text] [Related]
3. [PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease].
Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Hao L; Wang YZ; Jiang B; Lu XJ; Liu YR; Huang XJ; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):441-5. PubMed ID: 19035174
[TBL] [Abstract][Full Text] [Related]
4. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia.
Spanaki A; Perdikogianni C; Linardakis E; Kalmanti M
Leuk Res; 2007 May; 31(5):639-42. PubMed ID: 16860864
[TBL] [Abstract][Full Text] [Related]
6. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
[TBL] [Abstract][Full Text] [Related]
7. Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia.
Tajeddine N; Millard I; Gailly P; Gala JL
Clin Chem Lab Med; 2006; 44(5):548-55. PubMed ID: 16681423
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.
Qin Y; Zhu H; Jiang B; Li J; Lu X; Li L; Ruan G; Liu Y; Chen S; Huang X
Leuk Res; 2009 Mar; 33(3):384-90. PubMed ID: 18950857
[TBL] [Abstract][Full Text] [Related]
9. [Quantification of the PRAME transcripts in patients with acute myeloid leukemia].
Zhu ZH; Qian J; Lin J; Yao DM; Qian Z; Wang YL; Chen Q; Han LX; Xiao G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):149-52. PubMed ID: 20376794
[TBL] [Abstract][Full Text] [Related]
10. Correlation between preferentially expressed antigen of melanoma and tumour necrosis factor-related apoptosis-inducing ligand gene expression in different types of leukaemia patients.
Zhang W; Chi K; Zhang Y; Ma B; Shi J; Chen Y; Lei P; Li Y; Sun K
Acta Haematol; 2013; 130(4):297-304. PubMed ID: 24008770
[TBL] [Abstract][Full Text] [Related]
11. PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia.
Steinbach D; Pfaffendorf N; Wittig S; Gruhn B
Cancer Genet Cytogenet; 2007 Aug; 177(1):51-4. PubMed ID: 17693191
[TBL] [Abstract][Full Text] [Related]
12. Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
Ortmann CA; Eisele L; Nückel H; Klein-Hitpass L; Führer A; Dührsen U; Zeschnigk M
Ann Hematol; 2008 Oct; 87(10):809-18. PubMed ID: 18587578
[TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of real-time fluorescence PCR quantification of hepatocyte growth factor mRNA expression in acute leukemia].
Cen D; Lü JX; Pei RZ; Tu ZG; Yu XL; Wen YA
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):401-4. PubMed ID: 18953951
[TBL] [Abstract][Full Text] [Related]
14. [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance].
Zhang R; Sun HQ; Li G; Bai FY; Yang Y; Jing Q; Shi YJ; Yang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):959-63. PubMed ID: 21867623
[TBL] [Abstract][Full Text] [Related]
15. [Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].
Lu D; Qin YZ; Li LD; Shi HX; Lai YY; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):370-6. PubMed ID: 24763007
[TBL] [Abstract][Full Text] [Related]
16. Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies.
Matsushita M; Yamazaki R; Ikeda H; Kawakami Y
Leuk Lymphoma; 2003 Mar; 44(3):439-44. PubMed ID: 12688312
[TBL] [Abstract][Full Text] [Related]
17. Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia.
Matsushita M; Ikeda H; Kizaki M; Okamoto S; Ogasawara M; Ikeda Y; Kawakami Y
Br J Haematol; 2001 Mar; 112(4):916-26. PubMed ID: 11298586
[TBL] [Abstract][Full Text] [Related]
18. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
19. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.
Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S
J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618
[TBL] [Abstract][Full Text] [Related]
20. PRAME Gene Expression in Acute Leukemia and Its Clinical Significance.
Ding K; Wang XM; Fu R; Ruan EB; Liu H; Shao ZH
Cancer Biol Med; 2012 Mar; 9(1):73-6. PubMed ID: 23691459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
